Numerical simulation helps researchers screen potential drug molecules virtually before spending money on lab tests.
Molecular Dynamics could be run on a protein target with thousands of candidate ligands docked into the active site, then watch how stable the binding is over nanoseconds or microseconds
Monte Carlo methods is used in free-energy perturbation calculations to rank how tightly different drugs bind, the result is faster lead optimization and fewer failed clinical trials.
Case example
One common application is studying membrane proteins like G-protein coupled receptors which are major drug targets. Research ran simulations on GPCRs embedded in a realistic lipid bilayer to see how protein moves and how drugs bind.
They used all-atom Molecular Dynamics with force fields like CHARMM or AMBER to simulate the receptor over nanoseconds to microseconds. This revealed hidden binding pockets that only open during motion and helped calculate binding stability.
Molecular Dynamics helped explain why some drug candidates bind better than others and guided the design of more selective ligands. It also showed how the surrounding membrane affects drug entry, something static docking misses.
It matters for accuracy and cost. Standard classical force field gave good agreement with experimental data for conformational changes. But for very long times, they need special hardware like Anton supercomputers which can speed things up dramatically.